Franklin Genomic Advancements Etf (HELX) Technical Analysis

$34.29▲-0.67%

Insights

Franklin Genomic Advancements Etf is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Based on analysis of the Oscillators technical indicator, the current market trend for Franklin Genomic Advancements Etf stock suggests that it is a good time to sell or bad time to initiate a fresh position
Based on analysis of the Moving Averages technical indicator, Franklin Genomic Advancements Etf stock is in a uptrend ↗️
Based on analysis of the Pivot Points, the current market trend for Franklin Genomic Advancements Etf stock suggests that it is a good time to sell or bad time to initiate a fresh position

Analysis Summary

Oscillators

Sell

Neutral

Buy

Moving Averages

Sell

Neutral

Buy

Pivots

Sell

Neutral

Buy

Oscillators

Name	Value	Action
Relative Strength Index	66.47	Sell
Stochastic	88.56, 95.42	Sell
Ultimate Oscillator	61.88	Neutral
Stochastic Relative Strength Index	49.32, 41.28	Neutral
Moving Average Convergence Divergence	0.88, 0.82	Buy

Moving Averages

Simple Moving Average

Period (Days)	Value	Action
10	33.78	Buy
20	33.11	Buy
50	31.38	Buy

Exponential Moving Average

Period (Days)	Value	Action
10	33.75	Buy
20	33.08	Buy
50	31.62	Buy

Volume Weighted Moving Average

Period (Days)	Value	Action
10	33.45	Neutral
20	32.36	Buy
50	31.3	Buy

Double Exponential Moving Average

Period (Days)	Value	Action
10	34.4	Buy
20	34.25	Buy
50	33.53	Buy

Triple Exponential Moving Average

Period (Days)	Value	Action
10	34.42	Sell
20	34.46	Buy
50	34.14	Buy

Pivot

Pivot	Value
Resistance L3	34.75
Resistance L2	34.63
Resistance L1	34.58
Pivot Point	34.46
Support L1	34.41
Support L2	34.29
Support L3	34.24

*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.